三博脑科收盘上涨1.28%，滚动市盈率94.75倍，总市值104.13亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Sanbo Brain Science, indicating a significant increase in shareholder numbers and a high PE ratio compared to industry averages [1][2] - As of July 4, Sanbo Brain Science's closing price was 50.55 yuan, with a PE ratio of 94.75 times, and a total market capitalization of 10.413 billion yuan [1] - The average PE ratio for the medical services industry is 41.66 times, with a median of 43.26 times, positioning Sanbo Brain Science at the 39th rank within the industry [1][2] Group 2 - As of March 31, 2025, the number of shareholders for Sanbo Brain Science increased to 37,673, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] - The main business of Sanbo Brain Science includes clinical medical services, with key products being medical services, pharmaceuticals, and supply chain operations [1] - In the first quarter of 2025, the company reported revenue of 393 million yuan, a year-on-year increase of 16.78%, and a net profit of 38.3136 million yuan, reflecting a year-on-year growth of 14.56%, with a gross margin of 26.44% [1]